2008
DOI: 10.1016/j.bbapap.2008.04.021
|View full text |Cite
|
Sign up to set email alerts
|

Ligand reactivity and allosteric regulation of hemoglobin-based oxygen carriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0
1

Year Published

2009
2009
2014
2014

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 201 publications
0
11
0
1
Order By: Relevance
“…[ 24,25 ] As a Food and Drug Administration (FDA) approved polymer for human use in drug and cosmetic applications, [ 24 ] PEG has also been widely investigated for tissue engineering, including ophthalmic applications. [ 26 ] For such applications, PEG is often combined with natural materials such as collagen or cell adhesion ligands such as RGD (Arginine-Glycine-Aspartic amino acid sequence common in proteins such as collagen and fi bronectin) for improved cell-surface interactions and attachment.…”
Section: Introductionmentioning
confidence: 99%
“…[ 24,25 ] As a Food and Drug Administration (FDA) approved polymer for human use in drug and cosmetic applications, [ 24 ] PEG has also been widely investigated for tissue engineering, including ophthalmic applications. [ 26 ] For such applications, PEG is often combined with natural materials such as collagen or cell adhesion ligands such as RGD (Arginine-Glycine-Aspartic amino acid sequence common in proteins such as collagen and fi bronectin) for improved cell-surface interactions and attachment.…”
Section: Introductionmentioning
confidence: 99%
“…33 This stabilization of relaxed state by PEG's hydration shell or modifications that help the transition of Hb from T to R conformation may be responsible for the lowering of p50. 13 However, in the current method of conjugation, it is not feasible to know about which amino group perturbation is critical for lowering the p50 of Hb molecules and thus the lowering of the p50 of the final conjugates. 34 Interestingly, increasing the concentration of the PEG did not significantly lower the p50, which is contrary to our initial assumptions based on reports from the literature.…”
Section: Discussionmentioning
confidence: 99%
“…Polymerization and crosslinking offer a practical way to alter p50 that depends on the crosslinking agent and may be mediated by chemistry of the conjugation. 13 A typical approach described in the literature (glutaraldehyde as a conjugating agent) resulted in high p50, which is more relevant in normal conditions than the low p50 conditions encountered at the sites of transplantation. 14 Also, glutaraldehyde crosslinking is shown to promote unwanted effect of vasoconstriction 15 and release of the polymeric linker by degradation exhibiting cytotoxicity.…”
Section: Introductionmentioning
confidence: 98%
“…Conversely, the chemically linked Hb–SOD products described by Alagic [4] and Tarasov [5] have cross‐links introduced at different residues, as well as reactive groups, which must be blocked in a separate step. In these chemical linking approaches, usually both intra‐tetramer and inter‐tetramer bonds are introduced, with the involvement of multiple side chains [23]. In addition, it has been shown that shorter cross‐links may provide better stabilized Hb [24].…”
Section: Discussionmentioning
confidence: 99%